Motif Bio PLC (LON:MTFB) has conditionally raised £600,000 to facilitate the restructuring that will see it sell its iclaprim antibiotic and wind down the rest of its business.
Shareholders will also be asked to grant secured lender Hercules Capital a warrant over 20% of the group’s share capital following the placing.
Shares in the placing were issued at 0.42p.